Development asset linked to Advicenne in public FDA and regional records.
pharma · distal renal tubular acidosis (dRTA)
Advicenne
Advicenne S.A.
Advicenne drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Paris, FR HQ
16 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Paris, FR
- Employees
- 16
- Programs
- 1
- Drugs
- 2
- Patents
- 0
Advicenne pipeline
Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Advicenne drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
US regulatory status: approved. Molecular target: Sodium-dependent noradrenaline transporter.
- Target
- Sodium-dependent noradrenaline transporter
- Mechanism
- Norepinephrine transporter releasing agent